60 Degrees Pharmaceuticals, Inc. (SXTPW)

The security is trading at its absolute 52-week low, having recently dipped to $0.02, indicating severe near-term pressure and a lack of immediate catalysts to drive a bounce. The company carries a negative book value of nearly $1.80 per share, signaling that the liquidation value is deeply impaired and the balance sheet is fundamentally broken. With no analyst recommendations, no dividend history, and a complete absence of multi-year price trajectory data due to its status as a newly listed instrument, there is no evidence of sustained business quality or capital preservation. The statistical forecast suggests a slight upward lean over the next 45 days, but the model's confidence is explicitly low, rendering this a weak signal that cannot overcome the overwhelming fundamental distress.